# LifeMD, Inc.: filings

LFMD · Nasdaq · CIK 948320 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lfmd.md) · [Financials](/companies/lfmd/financials.md) · [Filings](/companies/lfmd/filings.md) · [Insiders](/companies/lfmd/insiders.md)

## Reports and events: 225 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 181, 8-K 139, 10-Q 41, 3 36, UPLOAD 16, 10-K 14, CORRESP 13, EFFECT 10, DEF 14A 9, DEFA14A 9, 144 7, 424B3 7, S-1/A 7, 424B5 6, S-8 6, SC 13G 6, 3/A 5, 4/A 5, D 5, 8-K/A 4, ARS 4, NT 10-Q 4, PRE 14A 4, S-1 4, S-3 4, S-3/A 4, 10-Q/A 3, 5 3, SC 13D 3, 8-A12B 2, CERT 2, POS AM 2, PRER14A 2, SC 13G/A 2, 8-A12G 1, CT ORDER 1, D/A 1, DEFR14A 1, FWP 1, NT 10-K 1, SC 13D/A 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 14:18 ET | [8-K](/filings/0001493152-26-042691.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042691 |
| 2026-08-05 | 20:51 ET | [10-Q](/filings/0001493152-26-036200.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036200 |
| 2026-08-05 | 20:10 ET | [8-K](/filings/0001493152-26-036170.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036170 |
| 2026-06-22 | 12:25 ET | [8-K](/filings/0001493152-26-029503.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029503 |
| 2026-05-06 | 21:24 ET | [10-Q](/filings/0001493152-26-021536.md) | Quarterly report, period 2026-03-31 | 0001493152-26-021536 |
| 2026-05-06 | 21:04 ET | [8-K](/filings/0001493152-26-021520.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-021520 |
| 2026-04-30 | 20:05 ET | [DEF 14A](/filings/0001493152-26-020419.md) | Proxy statement, period 2026-04-30 | 0001493152-26-020419 |
| 2026-03-18 | 20:16 ET | [8-K](/filings/0001493152-26-011228.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-011228 |
| 2026-03-10 | 20:56 ET | [10-K](/filings/0001493152-26-009549.md) | Annual report, period 2025-12-31 | 0001493152-26-009549 |
| 2026-03-09 | 20:37 ET | [8-K](/filings/0001493152-26-009380.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009380 |
| 2026-01-06 | 14:19 ET | [8-K](/filings/0001493152-26-000525.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-000525 |
| 2025-11-17 | 21:52 ET | [10-Q](/filings/0001493152-25-023906.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023906 |
| 2025-11-17 | 21:10 ET | [8-K](/filings/0001493152-25-023853.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023853 |
| 2025-11-05 | 22:27 ET | [8-K](/filings/0001493152-25-020913.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020913 |
| 2025-11-04 | 19:48 ET | [8-K](/filings/0001493152-25-020713.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020713 |
| 2025-08-21 | 20:30 ET | [8-K](/filings/0001493152-25-012214.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-25-012214 |
| 2025-08-05 | 20:46 ET | [10-Q](/filings/0001641172-25-022272.md) | Quarterly report, period 2025-06-30 | 0001641172-25-022272 |
| 2025-08-05 | 20:10 ET | [8-K](/filings/0001641172-25-022258.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022258 |
| 2025-07-31 | 20:36 ET | [8-K](/filings/0001493152-25-011523.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011523 |
| 2025-06-16 | 20:43 ET | [8-K](/filings/0001641172-25-015270.md) | 5.07 Shareholder vote results | 0001641172-25-015270 |
| 2025-05-06 | 20:45 ET | [10-Q](/filings/0001641172-25-008864.md) | Quarterly report, period 2025-03-31 | 0001641172-25-008864 |
| 2025-05-06 | 20:10 ET | [8-K](/filings/0001641172-25-008841.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-008841 |
| 2025-04-29 | 00:47 ET | [8-K](/filings/0001641172-25-006539.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-006539 |
| 2025-04-28 | 20:30 ET | [DEF 14A](/filings/0001641172-25-006444.md) | Proxy statement, period 2025-04-28 | 0001641172-25-006444 |
| 2025-04-25 | 20:33 ET | [8-K](/filings/0001641172-25-006228.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-006228 |
| 2025-03-11 | 12:57 ET | [10-K](/filings/0001493152-25-009790.md) | Annual report, period 2024-12-31 | 0001493152-25-009790 |
| 2025-03-10 | 20:10 ET | [8-K](/filings/0001493152-25-009690.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009690 |
| 2024-12-31 | 14:00 ET | [8-K](/filings/0001493152-24-052604.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-052604 |
| 2024-12-23 | 21:05 ET | [8-K](/filings/0001493152-24-051819.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-051819 |
| 2024-11-07 | 21:45 ET | [10-Q](/filings/0001493152-24-044032.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044032 |
| 2024-10-31 | 23:00 ET | [8-K](/filings/0001493152-24-043097.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-043097 |
| 2024-08-07 | 20:46 ET | [10-Q](/filings/0001493152-24-030564.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030564 |
| 2024-06-18 | 20:10 ET | [8-K](/filings/0001493152-24-024278.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-024278 |
| 2024-05-08 | 20:45 ET | [10-Q](/filings/0001493152-24-018250.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018250 |
| 2024-05-02 | 20:10 ET | [8-K](/filings/0001493152-24-017571.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017571 |
| 2024-04-29 | 20:59 ET | [DEF 14A](/filings/0001493152-24-017032.md) | Proxy statement, period 2023-12-31 | 0001493152-24-017032 |
| 2024-03-11 | 20:30 ET | [10-K](/filings/0001493152-24-009581.md) | Annual report, period 2023-12-31 | 0001493152-24-009581 |
| 2023-12-13 | 11:15 ET | [8-K](/filings/0001493152-23-044648.md) | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-044648 |
| 2023-11-14 | 21:19 ET | [8-K](/filings/0001493152-23-041139.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-041139 |
| 2023-11-08 | 21:46 ET | [10-Q](/filings/0001493152-23-039923.md) | Quarterly report, period 2023-09-30 | 0001493152-23-039923 |
| 2023-08-10 | 10:07 ET | [8-K](/filings/0001493152-23-027430.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-027430 |
| 2023-08-09 | 20:31 ET | [10-Q](/filings/0001493152-23-027367.md) | Quarterly report, period 2023-06-30 | 0001493152-23-027367 |
| 2023-07-31 | 21:30 ET | [8-K](/filings/0001493152-23-026121.md) | 5.02 Departure or appointment of officers or directors | 0001493152-23-026121 |
| 2023-07-14 | 20:05 ET | [8-K](/filings/0001493152-23-024593.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-024593 |
| 2023-07-07 | 20:05 ET | [8-K](/filings/0001493152-23-023977.md) | 5.07 Shareholder vote results | 0001493152-23-023977 |
| 2023-06-22 | 21:01 ET | [8-K](/filings/0001493152-23-022145.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-022145 |
| 2023-06-20 | 21:35 ET | [8-K](/filings/0001493152-23-021726.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-021726 |
| 2023-05-12 | 13:24 ET | [10-Q](/filings/0001493152-23-016516.md) | Quarterly report, period 2023-03-31 | 0001493152-23-016516 |
| 2023-04-28 | 13:11 ET | [DEF 14A](/filings/0001493152-23-014083.md) | Proxy statement, period 2023-04-28 | 0001493152-23-014083 |
| 2023-03-23 | 00:12 ET | [8-K](/filings/0001493152-23-008607.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-008607 |

Page 1 of 5. [Older](/companies/lfmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.